-transparent.png){kind=logo}
A stimulatory role for cAMP in the regulation of receptor-activated phosphoinositide hydrolysis has been examined in human SK-N-MCIXC and SK-N-MCIIE neuroepithelioma cells. The addition of optimal concentrations of oxotremorine-M, norepinephrine, endothelin-1, and ATP enhanced the release of inositol phosphates by 2-9-fold after activation of muscarinic, alpha 1-adrenergic, endothelin, and P2 nucleotide receptors, respectively. All combinations of these agonists elicited a release of inositol phosphates that was at least additive. However, the combined presence of oxotremorine-M and norepinephrine resulted in a phosphoinositide hydrolysis that was 30% greater than additive. This potentiation of inositol lipid hydrolysis resulted from an increased activity of the muscarinic receptor after the addition or norepinephrine and persisted after alpha 1-adrenergic receptor blockade. The enhancement of muscarinic receptor-stimulated inositol phosphate release could be quantitatively mimicked by inclusion of the beta-adrenergic agonist isoproterenol (EC50 approximately 0.1 microM), but not by alpha 1- or alpha 2-adrenergic agonists. Potentiation of oxotremorine-M-stimulated inositol lipid hydrolysis observed in the presence of either norepinephrine or isoproterenol was reduced in the absence of added Ca2+. Addition of either norepinephrine or isoproterenol to SK-N-MCIXC cells also resulted in a 16-fold increase in cAMP concentration. Although the cell-permeant 8-chloro-4-phenylthio-cAMP had a small inhibitory effect on basal inositol phosphate release, its inclusion resulted in a 19-31% enhancement of muscarinic, endothelin, ATP, and alpha 1-adrenergic receptor-stimulated phosphoinositide hydrolysis. We conclude 1) that, in SK-N-MCIXC cells, the addition of beta-adrenergic agonists selectively enhances muscarinic receptor-stimulated phosphoinositide hydrolysis through a cAMP-dependent process and 2) that the ability of exogenously added cAMP to enhance the activation of all four inositol lipid-linked receptors indicates that the effects of cAMP on inositol lipid hydrolysis are compartmentalized in these cells.
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
September 1974,
Nature,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
June 1991,
Journal of neurochemistry,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
November 1989,
Journal of neurochemistry,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
June 1978,
Nature,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
March 1992,
Neuroscience letters,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
February 1992,
Japanese journal of pharmacology,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
February 1995,
Neuroreport,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
May 1992,
Journal of neurochemistry,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
November 1992,
Neuroscience letters,
S K Fisher, and
E L McEwen, and
S C Lovell, and
R E Landon
July 1989,
Investigative ophthalmology & visual science,
